respiratori
tract
infect
rti
pneumonia
major
global
health
problem
account
childhood
infect
caus
bacteria
streptococcu
pneumonia
commonli
resid
healthi
upper
respiratori
tract
embed
complex
microbi
ecosystem
refer
microbiom
carriag
socal
pathobiont
prerequisit
diseas
carriag
densiti
associ
invas
pneumococc
although
factor
govern
acquisit
vital
rti
incomplet
understood
initi
colon
subsequ
dynam
like
impact
local
microbiota
process
call
colon
resist
direct
immun
concept
colon
resist
may
like
also
prevent
pathogen
overgrowth
respiratori
may
therefor
causal
role
pneumococc
colon
elimin
process
pneumococc
colon
affect
viral
coinfect
notabl
spanish
influenza
epidem
major
influenza
fatal
like
caus
secondari
pneumococc
role
influenza
acquisit
bloom
pneumococci
demonstr
control
experiment
infect
model
use
wildtyp
influenza
studi
test
liveattenu
influenza
vaccin
laiv
mechanist
pathway
partli
howev
less
known
effect
viral
infect
resid
respiratori
microbiota
vice
address
question
studi
bacteri
commun
dynam
follow
pneumococc
challeng
colon
without
anteced
viral
infect
use
experiment
human
pneumococc
challeng
ehpc
model
healthi
adult
volunt
challeng
serotyp
pneumococc
strain
random
receiv
either
tetraval
inactiv
influenza
vaccin
control
laiv
model
colon
rate
expect
primari
found
anteced
laiv
vaccin
laiv
administr
follow
pneumococc
colon
impact
overal
pneumococc
acquisit
yet
drive
time
acquisit
transient
increas
pneumococc
carriag
rate
densiti
approxim
compar
control
hypothes
nasal
microbiota
baselin
affect
likelihood
densiti
success
pneumococc
colon
furthermor
hypothes
effect
pneumococc
challeng
alon
ie
without
subsequ
success
colon
limit
effect
nasal
microbiota
dynam
stabil
last
anticip
perturb
caus
pneumococc
carriag
augment
group
receiv
laiv
ie
coinfect
attenu
influenza
viru
baselin
characterist
particip
describ
supplementari
tabl
volunt
screen
pneumococc
carriag
baselin
fig
individu
posit
natur
pneumococc
carriag
exclud
analysi
n
analys
sampl
particip
total
sequenc
lytaquantit
pcr
qpcr
supplementari
tabl
addit
baselin
sampl
screen
viral
coinfect
extens
describ
separ
volunt
becam
highdens
becam
lowdens
carrier
remain
volunt
n
neg
pneumococc
carriag
either
day
ie
noncarri
carriag
outcom
also
tightli
relat
pneumococc
densiti
carriag
calcul
area
lyta
curv
supplementari
fig
sequenc
qualiti
control
observ
total
oper
taxonom
unit
otu
repres
bacteri
phyla
presenc
natur
viral
coinfect
baselin
detect
sampl
first
assess
associ
baselin
nasal
microbiota
composit
natur
viral
coinfect
ie
pneumococc
inocul
vaccin
pneumococc
carriag
outcom
detect
signific
associ
baselin
nasal
microbiota
composit
consecut
pneumococc
carriag
outcom
effect
stronger
outcom
volunt
stratifi
highdens
lowdens
noncarri
base
convent
cultur
qpcr
data
permut
multivari
analysi
varianc
permanova
p
fig
tabl
supplementari
fig
compar
outcom
volunt
dichotom
carrier
noncarri
base
cultur
supplementari
fig
supplementari
tabl
import
semiquantit
inform
pneumococc
densiti
analys
support
borderlin
signific
associ
baselin
microbiota
composit
densiti
pneumococc
colon
day
p
supplementari
tabl
interestingli
volunt
becam
lowdens
carrier
demonstr
lowest
presenc
natur
respiratori
virus
baselin
intervent
show
lowest
rate
replic
influenza
viru
follow
laiv
vaccin
compar
highdens
noncarri
supplementari
tabl
associ
independ
supplementari
tabl
thu
studi
potenti
interact
viral
coinfect
microbiota
composit
pneumococc
outcom
observ
associ
baselin
microbiota
pneumococc
carriag
acquisit
depend
viral
coinfect
baselin
laiv
vaccin
p
p
respect
tabl
stratifi
analysi
suggest
howev
associ
microbiota
outcom
slightli
weaker
laiv
cohort
compar
control
cohort
vs
respect
supplementari
fig
suggest
interact
natur
viral
coinfect
iatrogen
laiv
infect
baselin
nasal
microbiota
pneumococc
carriag
recept
assess
microbiota
dynam
perform
averag
linkag
hierarch
cluster
use
dissimilar
found
cluster
microbiota
profil
cluster
compris
sampl
repres
total
sampl
supplementari
fig
identifi
otu
discrimin
cluster
use
random
forest
algorithm
refer
biomark
speci
supplementari
fig
largest
cluster
sta
n
character
staphylococcu
spp
follow
cluster
typifi
sever
corynebacterium
abund
corynebacterium
dolosigranulum
spp
cdg
n
separ
corynebacterium
cluster
cor
n
five
rarer
cluster
character
haemophilu
spp
hph
n
peptoniphilu
anaerococcu
finegoldia
spp
streptococcu
salivariu
pepmix
n
moraxella
spp
mor
n
fusobacterium
fu
n
streptococcu
spp
str
n
compris
sampl
fig
supplementari
fig
supplementari
tabl
line
previou
find
cluster
distribut
baselin
significantli
differ
lowdens
noncarri
fisher
exact
test
mont
carlo
simul
p
baselin
differ
relat
higher
proport
cdg
profil
lowdens
carrier
vs
noncarri
vs
respect
p
contrariwis
although
nonsignific
lowdens
carrier
specif
lack
stadomin
profil
compar
noncarri
vs
respect
p
highdens
carrier
p
result
confirm
stratifi
analysi
cluster
base
baselin
sampl
rule
potenti
confound
associ
profil
emerg
postchalleng
use
analysi
composit
microbiom
ancom
identifi
otu
present
baselin
associ
pneumococc
outcom
show
baselin
corynebacterium
dolosigranulum
posit
associ
lowdens
carrier
compar
noncarri
supplementari
fig
metagenomeseq
analysi
confirm
associ
corynebacterium
supplementari
fig
supplementari
tabl
moreov
use
metagenomeseq
detect
addit
consortium
lower
abund
otu
also
relat
outcom
otu
posit
associ
highdens
carrier
compar
lowdens
noncarri
belong
famili
prevotellacea
campylobacteracea
neisseriacea
facult
anaerob
primarili
resid
oral
caviti
supplementari
fig
supplementari
tabl
lower
abund
facult
anaerob
lowdens
carrier
also
associ
reduc
microbi
divers
compar
highdens
noncarri
wilcoxon
ranksum
test
p
p
respect
supplementari
fig
supplementari
tabl
independ
vaccin
group
base
stratifi
analys
supplementari
fig
supplementari
tabl
mucos
cytokin
data
assay
sampl
collect
day
supplementari
fig
first
assess
link
baselin
nasal
microbiota
cytokin
level
day
ie
follow
laiv
vaccin
regardless
outcom
use
canon
correspond
analysi
cca
distancebas
redund
analysi
dbrda
fig
intriguingli
otu
strongli
relat
first
two
axe
cca
dbrda
mostli
oraltyp
speci
includ
streptococcu
veillonella
prevotella
porphyromona
spp
previous
identifi
acquisitionassoci
microbiota
member
includ
dolosigranulum
corynebacterium
dbrda
colonystimul
factor
gmcsf
vascular
endotheli
growth
factor
vegf
consist
significantli
associ
baselin
nasal
microbiota
anovaccafunct
p
cytokin
level
day
significantli
lower
volunt
becam
lowdens
carrier
compar
noncarri
although
signific
laiv
control
group
upon
stratif
gmcsf
within
laiv
linear
model
p
supplementari
tabl
gener
volunt
becam
highdens
carrier
intermedi
cytokin
level
baselin
follow
combin
baselin
microbiota
plu
cytokin
data
studi
whether
combin
data
improv
classif
strength
outcom
inde
combin
data
show
larger
data
separ
microbiota
data
alon
fig
suggest
baselin
microbiota
composit
baselin
host
respons
drive
pneumococc
recept
next
analys
microbi
commun
behaviour
follow
pneumococc
challeng
found
overal
microbiota
composit
follow
pneumococc
challeng
becam
profoundli
differ
highdens
carrier
noncarri
lowdens
carrier
day
permanova
p
day
p
day
adjust
laiv
vaccin
presenc
viru
baselin
interact
outcom
vaccinenatur
viru
baselin
result
ident
exclus
otu
correspond
pneumonia
otu
tabl
suggest
broader
ecolog
impact
pneumococc
acquisit
challeng
microbiota
perturb
colon
singl
speci
pneumococcu
alon
day
pneumococc
carriag
nearli
elimin
microbiota
composit
outcom
group
becam
similar
p
strength
impact
laiv
per
se
presenc
replic
influenza
viru
day
nasal
microbiota
composit
highest
day
diminish
time
day
differ
overal
microbiota
composit
baselin
parallel
differ
unexpectedli
increas
microbi
divers
noncarri
compar
highdens
carrier
day
supplementari
fig
supplementari
tabl
suggest
ecolog
perturb
upon
pneumococc
challeng
independ
whether
strain
acquir
previous
describ
baselin
differ
microbiota
composit
relat
outcom
translat
variat
microbiota
dynam
follow
pneumococc
challeng
fig
measur
microbiota
profil
shift
follow
pneumococc
challeng
ie
day
compar
baselin
found
less
profil
chang
lowdens
carrier
compar
highdens
carrier
gener
linear
model
p
well
noncarri
p
tabl
line
chang
dissimilar
baselin
day
significantli
larger
highdens
carrier
compar
lowdens
carrier
tabl
p
larg
number
profil
chang
challeng
interv
noncarri
underscor
pneumococc
exposur
alon
without
subsequ
colon
anteced
vaccin
may
also
perturb
ecolog
equilibrium
cytokin
level
follow
laiv
preced
pneumococc
challeng
ie
day
lower
lowdens
carrier
compar
noncarri
supplementari
tabl
translat
lower
cytokin
level
whole
studi
period
area
curv
analys
day
linear
model
p
within
laiv
supplementari
tabl
addit
noncarri
higher
level
well
follow
pneumococc
challeng
compar
highdens
carrier
p
within
laiv
supplementari
tabl
suggest
pneumococc
acquisit
relat
variat
extend
laivinduc
mucos
inflamm
studi
associ
nasal
microbi
ecosystem
pneumococc
acquisit
densiti
context
natur
induc
laiv
viral
coinfect
control
human
coinfect
model
baselin
nasal
microbiota
composit
associ
pneumococc
outcom
contrari
hypothesi
largest
ecolog
differ
composit
mucos
inflamm
baselin
microbiota
profil
chang
directli
follow
pneumococc
exposur
observ
highdens
noncarri
lowdens
either
highdensenoncarri
furthermor
lowdens
carriag
associ
low
cytokin
level
limit
viral
coinfect
baselin
follow
lowest
laiv
replic
microbiota
perturb
least
mucos
inflamm
upon
acquisit
pneumonia
compar
highdens
noncarri
final
pneumococc
exposur
also
caus
perturb
nasal
microbiota
host
respons
even
carriag
establish
evid
regard
impact
nasal
microbiota
individu
recept
pneumococc
carriag
well
ecolog
reson
follow
pneumococc
exposur
limit
previou
studi
focuss
interact
differ
respiratori
pathogen
larg
disregard
ecolog
background
bacteria
embed
recent
nextgener
sequencingbas
studi
emerg
describ
associ
pneumococc
presenc
densiti
local
exampl
repeatedli
demonstr
corynebacterium
dolosigranulum
spp
abund
infant
neg
associ
pneumonia
colon
remain
howev
open
question
whether
observ
associ
causal
link
disentangl
relationship
bloom
pathobiont
chang
host
immun
respons
shift
microbiota
composit
complex
especi
cohort
studi
respiratori
infect
requir
longitudin
experiment
studi
approach
like
use
current
find
hint
toward
exist
specif
microbiota
constel
control
pneumococc
carriag
recept
interestingli
impact
nasal
microbiota
pneumococc
carriag
outcom
larger
control
laiv
recipi
suggest
interfer
normal
ecolog
process
influenza
viru
paradox
observ
import
nasopharyng
bacteri
commun
member
corynebacterium
dolosigranulum
spp
previous
associ
infant
respiratori
lowest
abund
noncarri
highest
lowdens
carrier
follow
highdens
carrier
baselin
although
latter
rel
pneumococc
abund
rare
domin
microbi
commun
adult
set
line
recent
communitybas
observ
show
cocolon
streptococcu
dolosigranulium
spp
relat
low
abund
streptococcu
addit
identifi
speciesrich
consortium
lowabund
facult
anaerob
otu
belong
among
other
prevotellacea
veillonellacea
famili
enrich
highdens
carrier
lesser
degre
noncarri
present
lowdens
carrier
speci
appear
also
strongli
relat
mucos
cytokin
profil
previou
studi
earli
presenc
bacteria
nasopharynx
children
associ
lack
microbiota
stabil
prematur
microbiota
matur
increas
risk
consecut
respiratori
well
sever
diseas
time
furthermor
vaccin
pneumococc
conjug
relat
temporari
enrich
among
other
veillonella
prevotella
fusobacterium
leptotrichia
spp
nonpneumococc
suggest
exist
biolog
interact
pneumococcu
therefor
hypothes
control
lowdens
colon
pneumonia
might
benefici
phenotyp
host
microb
base
less
ecolog
perturb
reduc
cytokin
level
observ
lowdens
carrier
contrast
especi
individu
fail
becom
colon
observ
strong
mucos
respons
combin
increas
microbiota
profil
chang
follow
challeng
observ
find
line
previou
observ
group
demonstr
pneumococc
exposur
follow
colon
still
associ
augment
antiprotein
immunoglobulin
respons
suggest
induct
host
immun
apart
differ
dolosigranulum
corynebacterium
spp
noncarri
compar
highdens
carrier
phenotyp
alik
suggest
case
physiolog
balanc
microbiota
immun
surveil
perturb
presum
contribut
selfenforc
dysbiosisinflamm
feedback
loop
acknowledg
bidirection
link
immun
respons
microbiota
like
explain
observ
highdens
carrier
noncarri
unimod
rather
linear
relationship
microbiota
composit
carriag
recept
identifi
sinc
previous
access
sampl
obtain
pneumococc
inocul
line
previou
work
group
focuss
relationship
laiv
pneumococc
current
find
underlin
import
molecular
pneumococc
detect
method
discern
lowdens
carrier
group
character
microbiota
chang
relat
laivinfluenza
viru
challeng
given
rel
larg
pneumococcusinduc
ecolog
perturb
observ
volunt
becam
highdens
noncarri
data
suggest
laiv
modestli
modul
microbiotamedi
recept
addit
impact
pneumococc
acquisit
densiti
induc
mucos
studi
includ
group
without
intervent
expect
pneumococc
exposur
follow
colon
would
strong
effect
local
microbiota
absenc
colon
anticip
current
find
healthi
adult
nuanc
compar
risk
popul
colon
infect
children
elderli
microbiota
composit
differ
immun
system
either
immatur
senesc
potenti
allow
identif
pronounc
impact
microbiotadriven
colon
futur
research
certainli
take
impact
pathobiont
exposur
follow
colon
account
especi
sinc
exposur
without
acquisit
might
vari
strongli
popul
group
detect
surveil
studi
furthermor
experiment
human
challeng
model
may
use
explor
interact
pathobiont
colon
administr
preprobiot
show
baselin
nasal
microbiota
composit
relev
determin
recept
pneumococc
colon
context
anteced
laiv
administr
use
molecular
techniqu
determin
pneumococc
presenc
enabl
us
detect
new
biolog
phenomena
show
particularli
lowdens
pneumococc
carriag
repres
characterist
stabl
mucos
equilibrium
compar
either
highdens
noncarri
ethic
approv
grant
liverpool
east
nh
research
committe
particip
gave
written
inform
consent
detail
studi
design
inexclus
criteria
particip
previous
found
supplementari
method
brief
healthi
nonsmok
adult
age
year
enrol
singlecentr
doubleblind
placebocontrol
trial
laiv
administ
prior
experiment
inocul
pneumococcu
pneumococc
colon
rate
densiti
particip
randomli
receiv
either
laiv
intramuscular
placebo
intramuscular
vaccin
pair
nasal
placebo
pneumococc
inocul
perform
previous
exclud
individu
carri
pneumococcu
base
cultur
baselin
ie
day
nasal
wash
sampl
pneumococc
detect
collect
day
addit
nasal
wash
perform
day
volunt
carriag
posit
day
andor
next
nasal
wash
process
describ
per
studi
protocol
pneumococc
detect
perform
use
convent
qpcr
target
pneumococc
lyta
nasal
line
fluid
sampl
hunt
develop
luminex
analysi
collect
store
previous
select
baselin
day
day
nasal
wash
sampl
four
time
point
fig
microbiota
analys
bacteri
dna
isol
resuspend
nasal
wash
pellet
see
supplementari
method
bead
beat
quantifi
use
qpcr
primer
direct
dna
subsequ
elut
one
aliquot
elut
buffer
store
analysi
amplicon
librari
gene
region
gener
sequenc
execut
previous
amplicon
pool
pairedend
sequenc
seven
run
use
illumina
miseq
instrument
illumina
inc
san
diego
ca
usa
bioinformat
process
includ
trim
error
correct
assembl
ident
bin
read
otu
follow
remov
chimer
read
otu
taxonom
annot
use
silva
detail
process
qualiti
control
remov
environment
procedur
contamin
describ
supplementari
method
abund
filter
rarefi
dataset
gener
use
downstream
analys
measur
averag
rarefact
assess
use
dissimilar
metric
nucleic
acid
viral
qpcr
extract
one
aliquot
oropharyng
swab
andor
nasosorpt
sampl
use
purelinktm
viral
rnadna
mini
kit
life
technolog
corpor
carlsbad
ca
usa
accord
manufactur
instruct
test
broad
panel
respiratori
virus
use
primer
probe
pcr
assay
condit
specif
adenovirus
parainfluenza
viru
human
human
coronaviru
respiratori
syncyti
viru
b
human
human
rhinovirus
enterovirus
human
influenza
viru
supplementari
tabl
cytokin
elut
store
nasosorpt
filter
use
assay
buffer
thermo
fisher
sampl
centrifug
min
g
clear
prior
acquisit
sampl
acquir
use
magnet
human
luminex
cytokin
kit
thermo
fisher
analys
biorad
softwar
luminex
corp
follow
manufactur
instruct
repres
subset
cytokin
select
analys
base
coclust
analys
sampl
analys
duplic
sampl
coeffici
variat
exclud
manuscript
describ
initi
result
laivehpc
project
focuss
effect
laiv
pneumococc
carriag
result
base
pneumococc
detect
method
ie
convent
cultur
molecular
present
underscor
import
increas
sensit
molecular
manuscript
therefor
decid
test
two
carriag
outcom
variabl
basi
nasal
wash
day
outcom
base
pneumococc
detect
use
convent
cultur
carrier
cultureposit
sampl
point
noncarri
cultureneg
time
outcom
combin
pneumococc
detect
use
convent
cultur
molecular
techniqu
code
highdens
carrier
cultureposit
point
lowdens
carrier
qpcrposit
cultureneg
noncarri
qpcr
cultureneg
everi
point
initi
explor
analys
demonstr
higher
explanatori
power
outcom
variabl
incorpor
qpcr
result
therefor
decid
use
outcom
variabl
throughout
rest
manuscript
instead
outcom
analys
perform
r
version
within
r
studio
version
provid
detail
schemat
research
questionsassoci
explor
data
analysi
flow
chart
depict
overview
method
use
supplementari
fig
detail
inform
statist
analysi
found
supplementari
method
short
use
permanova
test
studi
associ
carriag
outcom
overal
microbiota
composit
baselin
subsequ
time
point
conjunct
assess
associ
microbiota
composit
month
ie
season
effect
presenc
viru
es
baselin
interact
laiv
presenc
virus
baselin
carriag
outcom
relationship
microbiota
composit
carriag
outcom
visual
use
nmd
plot
differenti
abund
otu
baselin
associ
pneumococc
outcom
detect
use
sever
statist
techniqu
includ
differ
accord
outcom
test
use
wilcoxon
ranksum
test
linear
mixedeffect
model
carriag
outcom
time
point
interact
carriag
outcom
time
point
fix
effect
subject
random
effect
use
multcomp
packag
determin
signific
differ
within
specif
contrast
assess
microbiota
dynam
relat
outcom
time
perform
unsupervis
averag
linkag
hierarch
cluster
base
dissimilar
matrix
optim
number
cluster
biomark
cluster
determin
previous
comparison
cytokin
level
accord
outcom
perform
use
linear
model
includ
vaccin
carriag
outcom
interact
vaccin
carriag
outcom
simultan
assess
associ
baselin
nasal
microbiota
day
cytokin
level
use
cca
dbrda
inform
research
design
avail
natur
research
report
summari
link
articl
